Form 8-K - Current report:
SEC Accession No. 0001193125-25-266974
Filing Date
2025-11-05
Accepted
2025-11-05 16:15:45
Documents
12
Period of Report
2025-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-20251105.htm   iXBRL 8-K 54373
2 EX-99.1 adpt-ex99_1.htm EX-99.1 486189
3 GRAPHIC img119828894_0.jpg GRAPHIC 7887
  Complete submission text file 0001193125-25-266974.txt   686264

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20251105.xsd EX-101.SCH 30680
14 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20251105_htm.xml XML 4773
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 251454219
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)